Načítá se...
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
AIMS: In December 2019, the Coronavirus disease-2019 (COVID-19) virus has emerged in Wuhan, China. In this research, the first resolved COVID-19 crystal structure (main protease) was targeted in a virtual screening study by of FDA approved drugs dataset. In addition, a knowledge gap in relations of...
Uloženo v:
| Vydáno v: | Life Sci |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7194560/ https://ncbi.nlm.nih.gov/pubmed/32251634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2020.117627 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|